These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1240 related articles for article (PubMed ID: 23729473)

  • 1. Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases.
    Sajjadi SA; Acosta-Cabronero J; Patterson K; Diaz-de-Grenu LZ; Williams GB; Nestor PJ
    Brain; 2013 Jul; 136(Pt 7):2253-61. PubMed ID: 23729473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships.
    Snowden JS; Thompson JC; Stopford CL; Richardson AM; Gerhard A; Neary D; Mann DM
    Brain; 2011 Sep; 134(Pt 9):2478-92. PubMed ID: 21840888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.
    Lehéricy S; Hartmann A; Lannuzel A; Galanaud D; Delmaire C; Bienaimée MJ; Jodoin N; Roze E; Gaymard B; Vidailhet M
    Brain; 2010 Aug; 133(Pt 8):2410-25. PubMed ID: 20826434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
    Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion tensor imaging comparison of progressive supranuclear palsy and corticobasal syndromes.
    Whitwell JL; Schwarz CG; Reid RI; Kantarci K; Jack CR; Josephs KA
    Parkinsonism Relat Disord; 2014 May; 20(5):493-8. PubMed ID: 24656943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does corticobasal degeneration exist? A clinicopathological re-evaluation.
    Ling H; O'Sullivan SS; Holton JL; Revesz T; Massey LA; Williams DR; Paviour DC; Lees AJ
    Brain; 2010 Jul; 133(Pt 7):2045-57. PubMed ID: 20584946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies.
    Ferrer I; Hernández I; Boada M; Llorente A; Rey MJ; Cardozo A; Ezquerra M; Puig B
    Acta Neuropathol; 2003 Nov; 106(5):419-35. PubMed ID: 12955398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
    Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
    JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathological fingerprints of survival, atrophy and language in primary progressive aphasia.
    Mesulam MM; Coventry CA; Bigio EH; Sridhar J; Gill N; Fought AJ; Zhang H; Thompson CK; Geula C; Gefen T; Flanagan M; Mao Q; Weintraub S; Rogalski EJ
    Brain; 2022 Jun; 145(6):2133-2148. PubMed ID: 35441216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study.
    Madhavan A; Schwarz CG; Duffy JR; Strand EA; Machulda MM; Drubach DA; Kantarci K; Przybelski SA; Reid RI; Senjem ML; Gunter JL; Apostolova LG; Lowe VJ; Petersen RC; Jack CR; Josephs KA; Whitwell JL
    J Alzheimers Dis; 2016; 49(3):633-43. PubMed ID: 26484918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An 81-year-old woman with progressive motor disturbance, extrapyramidal features, dementia, and oculomotor palsy].
    Urabe T; Mori H; Sumino S; Miwa H; Wakiya M; Shirai T; Takubo H; Mizuno Y
    No To Shinkei; 1998 Mar; 50(3):291-301. PubMed ID: 9566008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter microstructural integrity and cognitive function in a general elderly population.
    Vernooij MW; Ikram MA; Vrooman HA; Wielopolski PA; Krestin GP; Hofman A; Niessen WJ; Van der Lugt A; Breteler MM
    Arch Gen Psychiatry; 2009 May; 66(5):545-53. PubMed ID: 19414714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter development in children with benign childhood epilepsy with centro-temporal spikes.
    Ciumas C; Saignavongs M; Ilski F; Herbillon V; Laurent A; Lothe A; Heckemann RA; de Bellescize J; Panagiotakaki E; Hannoun S; Marinier DS; Montavont A; Ostrowsky-Coste K; Bedoin N; Ryvlin P
    Brain; 2014 Apr; 137(Pt 4):1095-106. PubMed ID: 24598359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia.
    Hirano S; Shinotoh H; Shimada H; Aotsuka A; Tanaka N; Ota T; Sato K; Ito H; Kuwabara S; Fukushi K; Irie T; Suhara T
    Brain; 2010 Jul; 133(Pt 7):2058-68. PubMed ID: 20558417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration.
    Cotelli M; Borroni B; Manenti R; Alberici A; Calabria M; Agosti C; Arévalo A; Ginex V; Ortelli P; Binetti G; Zanetti O; Padovani A; Cappa SF
    Neuropsychology; 2006 Sep; 20(5):558-65. PubMed ID: 16938018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy.
    Giordano A; Tessitore A; Corbo D; Cirillo G; de Micco R; Russo A; Liguori S; Cirillo M; Esposito F; Tedeschi G
    Parkinsonism Relat Disord; 2013 Jun; 19(6):590-4. PubMed ID: 23477861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy.
    Kertesz A; McMonagle P
    J Neurol Sci; 2010 Feb; 289(1-2):138-43. PubMed ID: 19733862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of pathology in primary progressive language and speech disorders.
    Deramecourt V; Lebert F; Debachy B; Mackowiak-Cordoliani MA; Bombois S; Kerdraon O; Buée L; Maurage CA; Pasquier F
    Neurology; 2010 Jan; 74(1):42-9. PubMed ID: 19940270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter damage in primary progressive aphasias: a diffusion tensor tractography study.
    Galantucci S; Tartaglia MC; Wilson SM; Henry ML; Filippi M; Agosta F; Dronkers NF; Henry RG; Ogar JM; Miller BL; Gorno-Tempini ML
    Brain; 2011 Oct; 134(Pt 10):3011-29. PubMed ID: 21666264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
    Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
    Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.